tirzepatide 30mg vs 60mg Dual Agonist (GLP-1/GIP) Tirzepatide Pen 60 mg Support

Expected Weight Loss: In the head-to-head SURMOUNT-5 trial published in The New England Journal of Medicine , tirzepatide was shown to be superior to semaglutide for reduction in body weight and waist circumference at 72 weeks among adults with obesity (without diabetes)

however, their clinical validation doesn't match that of injections like Zepbound

MED+ New

Yes, this service counts towards your All points

Researchers are also focusing on real-world evidence to understand how semaglutide performs in everyday clinical practice

Staying hydrated, eating smaller frequent meals, and avoiding high-fat foods reduces severity